Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Blocklisting Interim Review

6 Feb 2008 08:31

PuriCore Plc06 February 2008 BLOCKLISTING SIX MONTHLY RETURN INFORMATION PROVIDED ON THIS FORM MUST BE TYPED OR PRINTED ELECTRONICALLY. To: The FSA Date: 6 February 2008 1. Name of applicant: PURICORE PLC INDIVIDUAL STERILOX TECHNOLOGIES STERILOX TECHNOLOGIES PURICORE EXECUTIVE2. Name of OPTION INC. SHARE OPTION INC.2004 SHARE OPTION OMNIBUS scheme GRANTS SCHEME 2005 SCHEME INCENTIVE PLAN WARRANTS 3. Period of return: From 31 AUGUST 2007 To 5 FEBRUARY 2008 4. Balance under scheme from previous return: 3,284,100 9,461,408 227,500 200,000 1,960,870 5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 2,754,850 2,929,842 NIL 4,104,231 211,077 6. Number of securities issued/allotted under scheme during period: NIL NIL NIL NIL 1,000,000 7. Balance under scheme not yet issued/ allotted at end of period 6,038,950 12,391,250 227,500 4,304,231 1,171,947 8. Number and class of securities originally listed and the date of admission 151,838,792 ORDINARY SHARES 9. Total number of securities in issue at the end of the period 151,888,792 ORDINARY SHARES Name of contact ANDREA HOLZMAN-DRUCKER, COMPANY SECRETARY Address of contact 58 DAVIES STREET, LONDON W1K 5JF UK Telephone number of contact +001 484 321 2761 Signed bycompany secretaryfor and on behalf of PURICORE PLCName of applicant If you knowingly or recklessly give false or misleading information you may beliable to prosecution. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Nov 20177:00 amRNSRealm: Preclinical Data on PR022 Published
17th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20177:00 amRNSRealm Therapeutics to Present at BIO-Europe® 2017
30th Oct 20177:00 amRNSRealm Presents Data at ACAAI Scientific Meeting
18th Oct 20177:00 amRNSHolding(s) in Company
18th Oct 20177:00 amRNSBlock Listing Application
17th Oct 20176:28 pmRNSHolding(s) in Company
16th Oct 20173:39 pmRNSHolding(s) in Company
16th Oct 20177:00 amRNSRealm Therapeutics to speak at BIO Investor Forum
13th Oct 20172:20 pmRNSHolding(s) in Company
13th Oct 20172:17 pmRNSHolding(s) in Company
12th Oct 20175:48 pmRNSHolding(s) in Company
12th Oct 20173:07 pmRNSRealm Therapeutics: Completion of £19.3m Placing
12th Oct 201711:04 amRNSHolding(s) in Company
12th Oct 201710:58 amRNSHolding(s) in Company
9th Oct 201711:35 amRNSResult of General Meeting
22nd Sep 20177:00 amRNSProposed Placing to raise £19.3 million
22nd Sep 20177:00 amRNSInterim Results
21st Sep 20176:01 pmRNSProposed Placing to raise £19.3 million
21st Sep 20176:00 pmRNSInterim Results
11th Sep 20177:00 amRNSFDA Permits PR013 to Proceed to Phase II Trial
7th Sep 20177:00 amRNSConference Presentation
18th Aug 20177:00 amRNSBlock listing Interim Review
2nd Aug 20177:00 amRNSSubmission of Investigational New Drug Application
6th Jul 20177:00 amRNSPresentation at World Congress on Inflammation
14th Jun 20177:09 amRNSPresentation at 2017 Marcum Microcap Conference
6th Jun 201711:05 amRNSResult of AGM
11th May 201712:21 pmRNSNotice of AGM
23rd Mar 20172:57 pmRNSAnnual Report and Accounts Available
23rd Mar 20177:00 amRNSFinal Results and Business Update
6th Mar 20177:00 amRNSConference Presentation
28th Feb 20177:00 amRNSFDA permits PR022 to Proceed to Phase 2 Trial
20th Feb 20177:00 amRNSBlock listing Interim Review
13th Feb 20177:00 amRNSPresentation at BIO CEO & Investor Conference
30th Jan 20177:00 amRNSResearch Update - Submission of first IND
5th Jan 20177:00 amRNSConference Presentations
4th Jan 20177:00 amRNSGrant of Options
21st Dec 20167:00 amRNSPDMR dealing
16th Dec 20167:00 amRNSIvan Gergel appointed as Non-Executive Director
7th Dec 20167:00 amRNSChange of name to Realm Therapeutics
18th Nov 20167:00 amRNSGrant of Options
17th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20167:00 amRNSDevelopment Programmes Update & Company Renaming
10th Oct 20167:00 amRNSCompletion of Supermarket Retail Business Disposal
7th Oct 20165:52 pmRNSCompletion of Supermarket Retail Business Disposal
6th Oct 201611:43 amRNSResult of General Meeting
23rd Sep 20162:47 pmRNSDirector/PDMR Dealing
22nd Sep 20162:15 pmRNSGrant of Options
20th Sep 20167:00 amRNSProposed Disposal of Supermarket Retail Business
20th Sep 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.